GE HealthCare CEO Peter Arduini declared orders growth in each of the company’s four segments in Q4 2024, continuing the commercial progress made since its spin out from GE Corp as “the largest healthtech start up in the industry” two years ago. The improved sentiment is partly due to a buoyant capital environment.
China Volatility Drags On Outlook For GE HealthCare But CAPEX More Buoyant
More NMP-Style Tuck-Ins Planned For Imaging Major That’s Rebranding Towards Healthcare Solutions
The US market’s largest imaging manufacturer marked two years as an independent company with plans to invest in more M&A and PDx production capacity, but reported a modest 2025 revenues outlook.
